Authors Giuliano S, Cormerais Y, Dufies M, Grépin R, Colosetti P, Belaid A, Parola J, Martin A, Lacas-Gervais S, Mazure NM, Benhida R, Auberger P, Mograbi B, Pagès G
Autophagy Jan 2015
FeCl3-promoted and ultrasound-assisted synthesis of resveratrol O-derived glycoside analogs.Authors Marzag H, Robert G, Dufies M, Bougrin K, Auberger P, Benhida R
Ultrasonics sonochemistry Jan 2015
The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells.Authors Hamouda MA, Belhacene N, Puissant A, Colosetti P, Robert G, Jacquel A, Mari B, Auberger P, Luciano F
Oncotarget Aug 2014
CD271 is an imperfect marker for melanoma initiating cells.Authors Cheli Y, Bonnazi VF, Jacquel A, Allegra M, De Donatis GM, Bahadoran P, Bertolotto C, Ballotti R
Oncotarget Jul 2014
Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines.Authors Cluzeau T, Dubois A, Jacquel A, Luciano F, Renneville A, Preudhomme C, Karsenti JM, Mounier N, Rohrlich P, Raynaud S, Mari B, Robert G, Auberger P
Oncotarget Jun 2014
cIAPs and XIAP reduce RIPKs to silence.Authors Jacquel A, Auberger P
Blood Apr 2014
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.Authors Willems L, Jacque N, Jacquel A, Neveux N, Maciel TT, Lambert M, Schmitt A, Poulain L, Green AS, Uzunov M, Kosmider O, Radford-Weiss I, Moura IC, Auberger P, Ifrah N, Bardet V, Chapuis N, Lacombe C, Mayeux P, Tamburini J, Bouscary D
Blood Nov 2013
Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine.Authors Cluzeau T, Mounier N, Karsenti JM, Richez V, Legros L, Gastaud L, Garnier G, Re D, Montagne N, Gutnecht J, Gabriel Fuzibet J, Auberger P, Raynaud S, Cassuto JP
American journal of hematology Sep 2013
Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.Authors Bertero T, Bourget-Ponzio I, Puissant A, Loubat A, Mari B, Meneguzzi G, Auberger P, Barbry P, Ponzio G, Rezzonico R
Cell cycle (Georgetown, Tex.) Jul 2013
Ponatinib circumvents all types of imatinib resistance in chronic myelogenous leukemia cell lines.Authors Dufies M, Cassuto O, Jacquel A, Robert G, Auberger P
Cell cycle (Georgetown, Tex.) Jun 2013